Horizons Marijuana Life Sciences Index ETF
Do CGC, ACB, TLRY, and APHA Look Cheap?
With the exception of Aphria, Tilray, Canopy Growth, and Aurora Cannabis were trading at a premium to the peer median EV-to-EBITDA multiple.
Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal
Jim Cramer said Altria’s acquisition of a 45% stake in Cronos Group last week was a “smart move” for Altria.
ACB, APHA, CTST, and HEXO Fall on March 20
The Horizons Marijuana Life Sciences ETF (HMMJ) had fallen by about 1.2% as of noon on March 20, while the ETFMG Alternative Harvest ETF (MJ) had declined by nearly 0.8%.
Markets Rebound but Cannabis Stock Performance Is Mixed
Markets rebounded today after the recent sell-off fueled by US-China trade tensions.
Canaccord Genuity Raises Price Target for Canopy Growth
On February 18, Canopy Growth (WEED) received a price target upgrade from Canaccord Genuity.
Top Developments in the Cannabis Industry’s Early Years
In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.
Cannabis Legalization: Four Governors Met in New York
The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.
Cannabis Investment: How to Buy ACB, CGC, and Other Stocks
Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.
Canopy Growth Receives Target Price Upgrades
Cormark Securities raised its target price for Canopy Growth to 40 Canadian dollars from 33 Canadian dollars, which represents an increase of almost 21%.
Tilray Invests in ROSE LifeScience
On December 14, Tilray (TLRY) announced that it’s investing in ROSE LifeScience—a cannabis producer in Quebec.
HEXO: Analysts’ Target Price and Ratings
CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.
Can Canopy Beat Q2 Estimates and Boost the Sector?
This week is important for the cannabis sector, as Canopy Growth and Aurora Cannabis are both set to report their earnings results on November 14.
Cannabis and Vaping Concerns: Will the Dream Go Up in Smoke?
Cannabis legalization is a vital topic in the US. Meanwhile, vaping related deaths continue to rise. Will vaping concerns kill the US cannabis dream?
Marijuana Vape Products Expected in Alberta Stores
AGLC will allow retail stores in Alberta to sell marijuana vape products. Consumers will likely be able to purchase cannabis vape products in the next two weeks.
Aurora Cannabis: What to Expect from Its Q4 Results
Aurora Cannabis should report its fourth-quarter earnings results on Thursday. So far, September has been positive. As of Monday, the stock has gained 8.7%.
Gundlach Compares Cannabis to Bitcoin
Jeffrey Gundlach predicted bitcoin’s (BTC) crash after the cryptocurrency’s peak in December 2017.
Big News: Cannabis Edibles in Alberta Stores
Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.
Marijuana Industry: Opportunities in California amid COVID-19
Marijuana is an old but growing market in California. Notably, California became the first state to legalize medical marijuana in 1996.
Tilray: Are Analysts Optimistic about Its Stock?
After Tilray’s second-quarter earnings, Benchmark reduced its target price to $80 from $120. Cowen and Company reduced the target price to $60 from $150.
Canada’s Cannabis Act C-45 Makes Progress in the Senate
On May 28, Bill C-45, Canada’s recreational cannabis legalization bill, saw further progress in the Senate.
Price Target Update for Canopy Growth in January
Canopy Growth (WEED) (CGC) has continued to deepen its roots in the United States with a recent announcement that could be a game changer.
MedMen’s Must-Know Revenue Drivers
MedMen’s (MMNFF) reported revenues are generated from direct sales through its retail stores. The company has reported no material revenues from cultivation or production wholesale operations.
Cannabis Sector: A Week in Review for Sept 20
Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.
Cannabis 2.0 Legalization: Canada Is Ready
Federally, cannabis legalization saw daylight in Canada in 2018. The Cannabis Act legalized recreational marijuana in October 2018. Now, the country is all set for the second wave of legalization, Cannabis 2.0, which includes cannabis edibles, cannabis-infused beverages, extracts, and various other products. Let’s dig into this more. Canada’s second wave of legalization Next month, […]
Cannabis Beverages: Why Canadians Can’t Wait
Deloitte estimates that the newly legalized cannabis beverage market could be worth 529 million Canadian dollars annually in Canada.
No Cannabis Edibles in Three Provinces for Christmas
After Canada legalized cannabis edibles in October, consumers hoped to buy these products this month. However, three provinces must wait until January.
Cannabis 2.0: Aurora Cannabis Gears Up for Edibles Market
Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market.
Why Cannabis Stocks Are on the Rise
The reason cannabis stocks are rising could be because October 17 is approaching.
Canopy Growth to Get Extract Supply from MediPharm Labs
On November 29, Canopy Growth (WEED) entered an 18-month supply agreement with MediPharm Labs.
How Aurora Cannabis’s Valuations Compare to Its Peers’
On January 18, Canopy Growth was trading at an EV-to-EBITDA multiple of 110.9x.
Cannabis Stocks Up, Broader Equity Market Falls
Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.
Canopy Growth Reported Its Q1 2019 Results on August 14
Canopy Growth reported its earnings for the first quarter of 2019 on August 14. The company is one of the largest cannabis producers by capacity.
IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks
It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.
CGC: How the Future Looks Under Its New CEO
On December 9, Canopy Growth (CGC) appointed David Klein as its new CEO effective January 14. He’s the current CFO of Constellation Brands.
Aurora Cannabis: Is This the Right Time to Invest?
Amid a subdued cannabis sector, Aurora Cannabis (ACB) stock has taken a serious hit and is down 36.4% this month. Is this the right time to invest?
How Canopy Growth Is Preparing for Legalized Cannabis
During 3Q18, Canopy Growth increased its inventory and biological assets to a value of 108.3 Canadian dollars from 56 million Canadian dollars in 3Q17.
Aphria: Analysts’ Target Price and Ratings
While Aphria’s consensus target price fell after its earnings, most analysts remain bullish on the stock. The overall “strong-buy” rating didn’t change.
Aurora Cannabis: Are Its Q4 Results Good or Bad News?
Aurora Cannabis reported its fourth-quarter results on Wednesday after the market closed. Did the company impress investors?
Tilray Makes a Bold Prediction on Cannabis Legalization in the US
Canopy Growth is preparing for the US market, but Tilray (TLRY) is not far behind.
New Year Will Bring Legal Marijuana to Illinois Residents
Marijuana products are top-rated among Americans. Illinois will see recreational marijuana products for sale on January 1.
Raymond James Foresees a Cannabis Rebound in 2020
Cannabis stocks had a difficult 2019. Besides cannabis companies losing out on revenue and profitability, many external factors also affected the sector. While pessimism drove the industry this year, a Raymond James analyst predicts things can turn around in 2020. Let’s take a look. Raymond James feels the cannabis sector could rebound On December 16, […]
The Market Is Sinking and Taking the Cannabis Sector Along
This morning turned brutal for the overall market with the S&P 500 Index sinking as much as 2.34% through the first half of the day on the back of the trade dispute between the United States and China.
Why Tilray Cannabis Stock Popped Today
On September 18, cannabis stock Tilray (TLRY) popped about 27% to an all-time high of $153.8 in the mid-day session.
Aurora Cannabis: What’s the Word on the Street?
Aurora Cannabis stock got a boost at the beginning of the month. The company updated its guidance for the fourth quarter.
Cannabis Stocks Had a Mixed Performance Last Week
Cannabis ETFs traded on a largely negative note last week.
Aurora Cannabis Releases Update on Cannabis 2.0
Aurora Cannabis (ACB) is going through a rough patch. This year, the company’s stock has lost 60.9% of its value as of December 23.
What’s the Market Potential for CBD?
The FDA has issued warning letters to 15 companies involved in illegal sales of non-psychoactive CBD products. What’s the legal market’s potential?
Key Developments in the Cannabis Sector Last Week
The week ending February 16 wasn’t so positive for marijuana stocks even though the broader market indexes ended in the positive territory.
Cannabis Stocks: Will Tough Times End Soon?
Cannabis players are having a hard time this year. Regulatory concerns and weaker earnings due to the vaping-related crisis took a toll on the sector.
Will Mexico Legalize Cannabis by the End of the Month?
With more countries now warming up to cannabis, let’s look at how Mexico is shaping up in terms of cannabis legalization.
Did MedMen’s Q3 Earnings Start a Path to Recovery?
MedMen released its results for the third quarter of fiscal 2020 on May 27. The stock declined 4.0% and closed at $0.35 on the OTC markets.
Coronavirus Revealed Cannabis Supply Chain’s Pitfalls
The cannabis industry has manufacturing operations in China. The coronavirus outbreak revealed some of the pitfalls in the marijuana supply chain.
Regulators Beware: Cannabis Linked to Job Loss
Cannabis is slowly picking up steam again, with more states are pushing to legalize. However, it appears the challenges never end in the marijuana sector.
Planet 13 Inks Deal with Mike Tyson’s Cannabis Venture
Today, Planet 13 Holdings (PNTH) (PLNHF) announced that it had inked a purchase agreement with Tyson Ranch, which is owned by boxer Mike Tyson.
Cannabis Investing in 2019: A Year of Big Reversals
The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.
Cannabis Legalization: Dark Clouds Loom Post Debate
Cannabis legalization is gaining traction not only in the US but also globally. The third presidential Democratic debate was held on September 12.
MedReleaf Stock Rises on Aurora Cannabis Acquisition
Today, Aurora Cannabis (ACB)(ACBFF) announced that it agreed to acquire all of MedReleaf’s (MEDFF) outstanding common shares for about 3.2 billion Canadian dollars.
Canopy Growth Moves to Acquire Hiku Brands Company
On July 10, Canopy Growth (WEED) (CGC) announced that it had entered an agreement to acquire Hiku Brands Company (HIKU).
Marijuana Legalization Catches Federal Reserve Bank’s Attention
The spotlight is on marijuana legalization as the demand keeps surging. More states have stepped up to legalize either recreational or medical cannabis.
Raymond James Is Cautiously Optimistic about Cannabis Stocks
So far, cannabis stocks have rebounded in 2020, which investors expected. The marijuana industry struggled in 2019. Overall, the rebound will take time.
Why Does Jim Cramer Like Cronos Group and Aphria?
Cronos Group and Aphria are Jim Cramer’s top picks in the cannabis sector. Aphria’s upbeat earnings results restored investors’ faith in the sector.
Cannabis Corruption in the US: Trouble before Elections?
Cannabis legalization has taken a back seat in the US. Since the last Democratic debate, there hasn’t been much discussion about federal legalization.
Can Canopy Growth’s Q3 Earnings Lift the Cannabis Sector?
On Friday, Canopy Growth will report its third-quarter earnings before the market opens. Investors will be watching the results closely.
Is Aurora Cannabis Looking at a Consumer Business Acquisition?
Since Peltz has experience in the consumer market space, Aurora Cannabis is probably looking to make a deeper foray into the consumer space.
Marijuana Sales Soar amid Coronavirus Pandemic
Marijuana stocks are seeing a ray of hope amid the coronavirus pandemic. With self-quarantine and lockdowns in many cities, marijuana sales have risen.
Acreage Holdings: Analysts Weren’t Pleased after Disappointing Q1
Investors and analysts weren’t pleased with Acreage Holdings’ (OTCMKTS:ACRGF) results for the first quarter of 2020. The company posted another EBITDA loss.
Why Is Raymond James Bullish on Cronos Group?
Earlier this week, Rahul Sarugaser of Raymond James upgraded Cronos Group (NASDAQ:CRON) from “market perform” to “outperform.”
Aurora Cannabis’s Cost-Cutting Measures Made Analysts Bullish
Aurora Cannabis (NYSE:ACB) announced some business transformation plans on June 23. The plans included cost savings and margin improvement.
Aurora Cannabis Announces Job Cuts and Facility Closures
On Tuesday, Aurora Cannabis (NYSE:ACB) provided an update on its business transformation plan, which it announced earlier this year.
Why Canadian Cannabis Sales Dipped Slightly in April
In April, cannabis sales came in at $180.1 million—0.6% down from the March sales. So, considering the spike in March, the sales weren’t disappointing.
Why HEXO Stock Tanked More than 11% on Wednesday
On Wednesday, HEXO announced a new at-the-market equity program, which would allow it to issue common shares worth up to 34.5 million Canadian dollars.
Will the Abacus Health Acquisition Benefit Charlotte’s Web?
On June 11, Charlotte’s Web announced that it completed the acquisition of Abacus Health. The company’s performance wasn’t strong in the first quarter.
OrganiGram Stock Rose Due to New International Agreement
On Wednesday, OrganiGram Holdings (NASDAQ:OGI) announced that its subsidiary OrganiGram signed a supply agreement with Canndoc.
Green Thumb Industries Opens Its 46th Retail Store
On Monday, Green Thumb Industries (OTCMKTS:GTBIF) opened a Rise brand store in Chambersburg, Pennsylvania—its 46th store in the US.
Is Canopy Growth a ‘Buy’ after Its Recent Pullback?
Since Canopy Growth (NYSE:CGC)(TSE:WEED) reported its results for the fourth quarter of fiscal 2020, it has lost 22.4% of its stock value as of Tuesday.
Why Is HEXO Rising before Its Q3 Earnings?
HEXO (TSE:HEXO) will likely report its third-quarter earnings before the market opens on June 11. So far, HEXO has lost 58.9% of its stock value this year.
Aurora Cannabis Continues to Shine: Should You Book Profits?
As of June 5, Aurora Cannabis was trading at 18.79 Canadian dollars—a rise of 104.2% since it reported its third-quarter earnings.
How’s COVID-19 Impacting Cigarette and Cannabis Sales?
Layoffs amid COVID-19 led to a decline in disposable income, which had a negative impact on the cigarette and cannabis industries.
Why Does Paradigm Capital Favor OrganiGram Holdings?
Paradigm Capital analyst Corey Hammill is bullish on OrganiGram. He rated the stock as a “buy” with a target price of 4.00 Canadian dollars.
HEXO Launches New Tsunami Format, Targets Medical Customers
On Wednesday, HEXO launched its high-THC strain Tsunami in a new 30-gram pack exclusively for medical usage. The launch impressed investors.
Analysts Are Bearish after Canopy Growth’s Weak Q4 Earnings
Canopy Growth (NYSE:CGC)(TSE:WEED) reported its fourth-quarter earnings before the market opened on May 29. The company’s earnings were weak.
HEXO Received License Amendment, Stock Rose Monday
On Monday, HEXO announced that it received a license amendment from Health Canada for its manufacturing and processing facility in Belleville, Ontario.
Why Are Canadian Cannabis Companies Leaving Jamaica?
Canadian cannabis companies are frustrated by the Jamaican government’s inaction. They have decided to cut their losses and exit the Jamaican market.
Why Is Raymond James Bullish on OrganiGram?
Rahul Sarugaser of Raymond James is upbeat on OrganiGram Holdings (NASDAQ:OGI). The company amended its credit facility with the Bank of Montreal.
Why Analysts Still Aren’t Convinced about Aurora Cannabis
Since Aurora Cannabis reported its third-quarter earnings, Piper Sandler upgraded the stock from “underweight” to “neutral.” Analysts favor a “hold” rating.
Why Analysts Had Mixed Reactions to Aphria’s Q3 Earnings
On April 14, Aphria (NYSE:APHA) reported its third-quarter earnings. For the quarter, the company reported revenues of 144.4 million Canadian dollars.
Comparing Canopy Growth and Aurora Cannabis’s Valuation Multiples
Canopy Growth and Aurora Cannabis are two prominent players in the cannabis sector. So far in 2020, Canopy Growth has outperformed cannabis ETFs.
Will Aphria’s Q3 Earnings Lift the Cannabis Sector?
Analysts expect Aphria to report revenue of 130.6 million Canadian dollars in the third quarter—growth of 77.5% YoY and a sequential increase of 8.3%.
Bruce Linton: WEED and CRON Can Handle COVID-19 Storm
On April 6, Bruce Linton said that Canopy Growth (TSE:WEED) and Cronos Group (NASDAQ:CRON) are better equipped to withstand the COVID-19 storm.
What Can You Expect from Marijuana Stocks in April?
As of April 3, Aurora Cannabis stock has fallen 10%, while Canopy Growth has fallen 8.1%. Cronos Group and Hexo have fallen 2.6% and 19.3% in April.
Comparing OrganiGram and Aphria’s Valuation Multiples
So far this year, OrganiGram Holdings (NASDAQ:OGI) and Aphria (NYSE:APHA) have lost 11.0% and 36.7% of their stock price.
3 Cannabis Stocks Investors Should Watch as Markets Rebound
As the markets start to rebound, three cannabis stocks could deliver strong returns. Cannabis sales have increased amid the coronavirus outbreak.
Coronavirus: Marijuana Industry Asks for Federal Business Relief
Currently, the cannabis industry has pleaded with the federal government to help cannabis businesses during these distressing times.
Cannabis Stocks Outperformed Broader Equity Markets Last Week
Last week was the worst week since October 2008. However, the cannabis sector fared better than the broader equity markets.
Why Did Bank of America Upgrade Aphria and OrganiGram?
On March 19, Bank of America upgraded Aphria (NYSE:APHA) and OrganiGram Holdings (NASDAQ:OGI) due to the increased demand for cannabis.
Will Curaleaf Beat Analysts’ Expectations in Q4?
Curaleaf Holdings (OTCMKTS:CURLF) will report its fourth-quarter earnings after the market closes on March 24. Analysts are bullish on Curaleaf.
What to Expect from Charlotte’s Web’s Q4 Earnings
Charlotte’s Web Holdings (NYSEARCA:CWEB) will report its earnings for the fourth quarter of 2019 before the market opens on March 24.
Roth Capital Initiates Coverage on IIPR with a ‘Buy’ Rating
On March 16, Roth Capital initiated coverage on Innovative Industrial Properties (NYSE:IIPR) with a “buy” rating and a stock price of $110.
Will the Fed’s Rate Cut Help Marijuana Stocks?
The marijuana sector saw a sharp decline last week amid the global sell-off. The S&P 500 fell by 8.8% in the week ending on March 13.
Analysts Recommend a ‘Buy’ for Curaleaf before Its Q4 Earnings
As of Thursday, nine analysts covered Curaleaf. Among the analysts, eight recommend a “buy,” while one recommends a “hold.”